Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,968,589
+$761,016 QoQ
Shares Held
47,126
+2.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#1,002
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST FOUNDATION ADVISORS holds $34,560,047 across 8 Drug Manufacturers - General names. JNJ ranks #1 (34.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
47,126 | $11,968,589 | |
| 2 | LLY |
ELI LILLY & Co
|
5,869 | $7,039,455 | |
| 3 | AZN |
Astrazeneca PLC
|
18,550 | $3,517,450 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
24,720 | $3,123,124 | |
| 5 | PFE |
Pfizer Inc
|
121,118 | $2,916,521 | |
| 6 | ABBV |
AbbVie Inc.
|
10,123 | $2,547,351 | |
| 7 | MRK |
Merck & Co., Inc.
|
16,084 | $2,066,794 | |
| 8 | AMGN |
Amgen Inc
|
3,813 | $1,380,763 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,968,589 | 47,126 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $11,207,573 | 45,850 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $9,468,375 | 45,752 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $10,345,878 | 55,797 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $8,639,539 | 56,560 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,085,529 | 48,755 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $6,804,370 | 47,050 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,220,493 | 50,725 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,445,389 | 50,940 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $7,118,865 | 45,002 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $6,226,182 | 39,723 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,255,684 | 53,006 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $8,506,568 | 51,393 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,524,880 | 42,096 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,070,769 | 40,027 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,862,827 | 35,889 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,571,861 | 31,389 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,590,188 | 31,542 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $5,314,289 | 31,065 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,060,441 | 31,334 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,029,182 | 30,528 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,932,965 | 30,015 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $4,533,960 | 28,809 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,347,593 | 29,202 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,184,887 | 36,869 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,785,589 | 36,495 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||